Canbiola, Inc. (CANB) Announces New Chief Operations Officer to Oversee Daily Operations and Manufacturing

HICKSVILLE, NY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTC PINK: CANB) is pleased to announce the hire of Mr. David Posel as the Chief Operations Officer.

“We are excited that Mr. Posel is joining the Canbiola team. Mr. Posel is a pioneer in the CBD industry and his many years of experience in Operations and Manufacturing will allow our company to better manage our growth,” said Marco Alfonsi, Canbiola CEO. “David has the perfect background, having participated in the industry since its early stages.”

“I am really excited to come aboard and work with Canbiola, a fantastic and robust company. Our goal at Canbiola will be to formulate new products and to continuously improve our product quality. We will be focusing on natural products that symbiotically work with the bio-absorption and bio-delivery systems within the human body and we are poised to deliver the most advanced CBD products across the board,” said Mr. Posel.

As the Chief Operations Officer of Canbiola, David will expand the company’s product lines across the board, engage market leaders and produce first-to-market products for CBD industry worldwide.

David Posel started his earliest years as a metallurgical engineer at AGCO Metalex, a large precious metals refinery in Washington State. The son of a Ph.D. chemist, Boeing engineer and mathematics major, he quickly went on to the Semiconductor manufacturing industry for nearly a decade as a metallic silicon coatings engineer, leaving to attend ASU West in Arizona. With an engineering and metallurgical chemistry background, David switched gears to Organic agricultural production for an additional eight years. David was farm director and chief environmental scientist for what was once the oldest Organic farm in the state of Colorado before moving into the more advanced world of CBD, hemp production and custom product development. David has spent years earning the respect of CBD market leaders and forming solid business relationships both in the US and abroad. His career began by making the first CBD infused consumer product offered in the US with 99% isolate, ‘CrystalPure CBD’ which is now sold under the Canbiola brand.

Canbiola will be attending the Integrative Healthcare Symposium Annual Conference on February 22-24, 2018 in New York City. Come join us and learn about the benefits of our products. (Booth # 638)

About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.

Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states. The company has already launched several products found at www.canbiola.com.

The company also owns two technological solutions, WRAPmail (US Patent 8,572,275), which turns traditional email into a powerful marketing and branding tool, as well Prosperity Systems and the Bullseye platform of document management and compliance targeted at broker-dealers, public companies, and governmental agencies providing a flawless all-in-one solution for document management, retention and compliance.

Forward-looking statements and risks and uncertainties Matters discussed in this press release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.

Canbiola Investor Relations Email: IR@canbiola.com Phone: (516) 595-9544 website: http://www.canbiola.com Follow us on Twitter and Facebook

Source:Canbiola, Inc.